Phase I/ II Study of GEN1042 in Patients with Malignant Solid Tumors, including Pancreatic Cancer
The purpose of this phase I/II trial is to evaluate the safety and efficacy of GEN1042 in patients with locally advanced, or metastatic solid tumors, including pancreatic cancer.
Study ID: GCT1042-01
Trial Phase: Phase I/II
Trial Sponsor: Genmab
Therapies Used in This Trial: GEN1042